Vimarsana
Biggest News Aggregation in the World

Page 11 - Nasdaq Morf News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Nasdaq Morf. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Nasdaq Morf Today - Breaking & Trending Today

Morphic Announces Participation In Cowen 42nd Annual - Vimarsana News

Morphic Announces Participation In Cowen 42nd Annual

WALTHAM, Mass., March 04, 2022 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biopharmaceutical company developing a new generation of oral...

Research Analysts Issue Forecasts for Morphic Holding, Inc.'s Q1 2022 Earnings (NASDAQ:MORF) - Vimarsana News

Research Analysts Issue Forecasts for Morphic Holding, Inc.'s Q1 2022 Earnings (NASDAQ:MORF)

Morphic Holding, Inc. (NASDAQ:MORF – Get Rating) – Analysts at Jefferies Financial Group issued their Q1 2022 EPS estimates for Morphic in a research note issued to investors on Thursday, February 24th. Jefferies Financial Group analyst M. Yee anticipates that the company will post earnings per share of ($0.71) for the quarter. Jefferies Financial Group […]

Morphic Therapeutic Announces Appointment of Susannah Gray - Vimarsana News

Morphic Therapeutic Announces Appointment of Susannah Gray

Morphic Therapeutic Announces Appointment of Susannah Gray as Member of its Board of Directors Otello Stampacchia steps down, Vikas Goyal to leave Morphic Board at the end of current term April 28, 2021 16:01 ET | Source: Morphic Therapeutic Morphic Therapeutic Waltham, Massachusetts, UNITED STATES WALTHAM, Mass., April 28, 2021 (GLOBE NEWSWIRE) -- Morphic Therapeutic (Nasdaq: MORF), a biotechnology company developing oral integrin therapies, today announced the appointment of Susannah Gray to its Board of Directors. Ms. Gray is an accomplished l...

Morphic Therapeutic Announces Pricing of Upsized $245.0 Million Public Offering - Vimarsana News

Morphic Therapeutic Announces Pricing of Upsized $245.0 Million Public Offering

Morphic Therapeutic Announces Pricing of Upsized $245.0 Million Public Offering March 02, 2021 20:25 ET | Source: Morphic Therapeutic Morphic Therapeutic Waltham, Massachusetts, UNITED STATES WALTHAM, Mass., March 02, 2021 (GLOBE NEWSWIRE) -- Morphic Holding, Inc. (Nasdaq: MORF), a biopharmaceutical company developing a new generation of oral integrin therapies for the treatment of serious chronic diseases, today announced the pricing of an upsized underwritten public offering of 3,500,000 shares of its common stock at a price to the public of $70...